Sepsis pp 15-21 | Cite as

Pneumonia: How Did We Evolve? (Colombian Vision)

  • Marco A. Gonzalez


From the very beginning of the medical profession, some illnesses have created landmarks inthe development of medicine. One such illness is pneumonia, which has profoundly influenced medical semiology. Later, diagnostic images evolved, then microbiology and pharmacology. Currently, medicine based on evidence is evolving, with the imposition of score markings for diagnosis, treatment, classification, and hospitalization. Nevertheless, pneumonia continues to be an infection with high incidence and in some cases with a bad evolution and great social and economic costs.1–3


Respir Crit Moraxella Catarrhalis Atypical Pathogen Parapneumonic Effusion Endemic Fungus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mandell LA. Community-acquired pneumonia etiology, epidemiology, and treatment. Chest 1995; 108 (suppl): 35S - 42S.PubMedCrossRefGoogle Scholar
  2. 2.
    Niederman M, Ahmed Q. Community-acquired pneumonia in elderly patients. Clin Geriatr Med2003; 19: 101–20.Google Scholar
  3. 3.
    Marrie TJ. Community-acquired pneumonia epidemiology, etiology, and treatment. Infect Dis Clin North Am 1998; 12: 723–40.PubMedCrossRefGoogle Scholar
  4. 4.
    Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired lower respiratory tract infections: Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med 2001; 163: 1730–54.PubMedGoogle Scholar
  5. 5.
    Niederman MS, McCombs JS, Unger AN, et al. The cost of treating community acquired pneumonia. Clin Ther 1998; 20: 820–37.PubMedCrossRefGoogle Scholar
  6. 6.
    Marston BJ, Plouffe JF, File TM, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-based Pneumonia Incidence Study Group. Arch Int Med 1997; 157: 1709–18.CrossRefGoogle Scholar
  7. 7.
    File Jr TM, Tan JS. Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia. Curr Opin Pulm Med 1997; 3: 89–97.PubMedCrossRefGoogle Scholar
  8. 8.
    Reimer LG, Carroll KC. Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections. Clin Infect Dis 1998; 26: 742–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Chaparro C, Ortega H, Torres C, Giraldo H. Neumonfa adquirida en la comunidad. Revista Colombiana de Neumologia 1989; 1: 19–24.Google Scholar
  10. 10.
    Bartlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults: Guidelines for management. Clin Infect Dis 1998; 26: 811–38.PubMedCrossRefGoogle Scholar
  11. 11.
    Ewig S, Ruiz M, Mensa J, Marcos MA, Martinez JA, Arancibia F, Niederman MS, Torres A. Severe community-acquired pneumonia: Assessment of severity criteria. Am J Respir Crit Care Med 1998; 158: 1102–8.PubMedGoogle Scholar
  12. 12.
    Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991; 115: 428–36.PubMedGoogle Scholar
  13. 13.
    Smith P. What diagnostic tests are needed for community-acquired pneumonia? Med Clin North Americ 2001; 85: 1381–96.CrossRefGoogle Scholar
  14. 14.
    Reed WW, Byrd GS, Gates RH Jr, et al. Sputum Gram’s stain in community-acquired pneumonia: A meta-analysis. West J Med 1996; 165: 197.PubMedGoogle Scholar
  15. 15.
    Skerrett SJ. Diagnostic testing for community-acquired pneumonia. Clin Chest Med 1999; 20: 531.PubMedCrossRefGoogle Scholar
  16. 16.
    Plouffe JF, File TM, Breiman RF, et al. Reevaluation of the definition of Legionnaires’ disease: Use of the urinary antigen assay. Clin Infect Dis 1995; 20: 1286PubMedCrossRefGoogle Scholar
  17. 17.
    Schluger RW, Rom WN. The polymerase chain reaction in the diagnosis and evaluation of pulmonary infections. Am J Respir Crit Care Med 1995; 152: 11.PubMedGoogle Scholar
  18. 18.
    Heffner JE, Brown LK, Barbieri C, et al. Pleural fluid chemical analysis in parapneumonic effusions: A meta-analysis. Am J Respir Crit Care Med 1995;Google Scholar
  19. 19.
    Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980; 69: 507.PubMedCrossRefGoogle Scholar
  20. 20.
    Matthay RA, Moritz ED. Invasive procedures for diagnosing pulmonary infection. Clin Chest Med 1981; 2: 3.PubMedGoogle Scholar
  21. 21.
    El-Ebiary M, Torres A, Gonzalez J, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis 1993; 148: 1552.PubMedCrossRefGoogle Scholar
  22. 22.
    Torres A, El-Ebiary M. Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia. Chest 2000; 117: 1985.CrossRefGoogle Scholar
  23. 23.
    Busk MF, Rosenow EC 3d, Wilson WR. Invasive procedures in the diagnosis of pneumonia. Semin Respir Infect 1998; 3: 113.Google Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Marco A. Gonzalez

There are no affiliations available

Personalised recommendations